COX expression and PGE2 and PGD2 production in experimental acute and chronic gastric lesions

DeMaria, 2003, Coxibs-beyond the GI tract: renal and cardiovascular issues, J. Pain Symptom Manage., 25, S41, 10.1016/S0885-3924(02)00630-9 Halter, 2001, Cyclooxygenase 2, implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives, Gut, 49, 443, 10.1136/gut.49.3.443 Fukushima, 1990, Prostaglandin J2-anti-tumour and anti-viral activities and the mechanisms involved, Eicosanoids, 3, 189 Joh, 2003, The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells, Aliment. Pharmacol. Ther., 18, 133, 10.1046/j.1365-2036.18.s1.15.x Martel-Pelletier, 2003, Cyclooxygenase-2 and prostaglandins in articular tissues, Semin. Arthritis Rheum., 33, 155, 10.1016/S0049-0172(03)00134-3 Harris, 2002, Prostaglandins as modulators of immunity, Trends Immunol., 23, 144, 10.1016/S1471-4906(01)02154-8 Castrillo, 2000, Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-delta(12,14)-prostaglandin J(2) in activated murine macrophages, Mol. Cell. Biol., 20, 1692, 10.1128/MCB.20.5.1692-1698.2000 Rossi, 2000, Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase, Nature, 403, 103, 10.1038/47520 Nakajima, 2001, Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury, Gastroenterology, 120, 460, 10.1053/gast.2001.21191 Su, 1999, A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response, J. Clin. Invest., 104, 383, 10.1172/JCI7145 Kawahito, 2000, 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats, J. Clin. Invest., 106, 189, 10.1172/JCI9652 Jimenez, 2002, Mechanisms involved in protection afforded by l-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins, Dig. Dis. Sci., 47, 44, 10.1023/A:1013203217788 Sánchez-Fidalgo, 2004, Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective COX-2 inhibitor, Eur. J. Pharmacol., 505, 187, 10.1016/j.ejphar.2004.10.019 Motilva, 1996, Role of polymorphonuclear leukocytes and oxygen-derived free radicals in chronic gastric lesion induced by acetic acid in rat, Gen. Pharmacol., 27, 545, 10.1016/0306-3623(95)02025-X Du, 2002, Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine, J. Neurochem., 80, 771, 10.1046/j.0022-3042.2001.00737.x Sawaoka, 1997, Expression of the cyclooxygenase-2 gene in gastric epithelium, J. Clin. Gastroenterol., 25, S105, 10.1097/00004836-199700001-00018 Gretzer, 2001, Effects of specific inhibition of cyclooxygenase 1 and cyclooxygenase 2 in the rat stomach with normal mucosa and after acid challenge, Br. J. Pharmacol., 132, 1565, 10.1038/sj.bjp.0703955 Villegas, 2004, Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: Role of prostaglandins and inflammatory response, Life Sci., 74, 873, 10.1016/j.lfs.2003.07.021 Peskar, 2001, Role of cyclooxygenase-2 in gastric mucosal defense, Life Sci., 69, 2993, 10.1016/S0024-3205(01)01407-2 Perini, 2003, Mucosal repair and COX-2 inhibition, Curr. Pharm. Des., 9, 2207, 10.2174/1381612033454027 Yamamoto, 1999, Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs, J. Physiol. Paris, 93, 405, 10.1016/S0928-4257(99)00128-X Brzozowski, 2000, Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress, J. Physiol. Paris, 94, 83, 10.1016/S0928-4257(00)00145-5 Reddy, 1999, Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells, Biochem. Biophys. Res. Commun., 265, 205, 10.1006/bbrc.1999.1658 Mizuno, 1997, Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice, Gastroenterology, 112, 387, 10.1053/gast.1997.v112.pm9024292 Schmassmann, 1998, Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats, Br. J. Pharmacol., 123, 795, 10.1038/sj.bjp.0701672 Brzozowski, 2001, Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2, Digestion, 64, 15, 10.1159/000048835 Berenguer, 2002, Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors, Eur. J. Pharmacol., 442, 125, 10.1016/S0014-2999(02)01494-2 Matsumoto, 1999, Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages, Biochem. Biophys. Res. Commun., 230, 110, 10.1006/bbrc.1996.5894 Fournier, 1997, Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis, J. Biol. Chem., 272, 31065, 10.1074/jbc.272.49.31065 Naraba, 1998, Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages, J. Immunol., 160, 2974, 10.4049/jimmunol.160.6.2974 Brock, 1999, Arachidonic acid is preferentially metabolizated by cyclooxygenase-2 to prostacyclin and prostaglandin E2, J. Biol. Chem., 274, 11660, 10.1074/jbc.274.17.11660 Dieter, 2000, Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages, Biochem. Biophys. Res. Commun., 276, 488, 10.1006/bbrc.2000.3496 Longo, 1998, Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents, Prostaglandins Other Lipid Mediat., 56, 325, 10.1016/S0090-6980(98)00058-6 Watanabe, 1998, Absence of relation between the expression of cyclooxygenase isoforms and the synthesis of prostaglandin E2 in resident and thioglycollate-elicited macrophages in rats, Prostaglandins Other Lipid Mediat., 56, 7, 10.1016/S0090-6980(98)00039-2 Gao, 2003, Formation of prostaglandins E2 and D2 via the isoprostane pathway: mechanism for the generation of bioactive prostaglandins independent cyclooxygenase, J. Biol. Chem., 278, 28479, 10.1074/jbc.M303984200 Gilroy, 1998, Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation, Eur. J. Pharmacol., 355, 211, 10.1016/S0014-2999(98)00508-1 Gilroy, 1999, Inducible cyclooxygenase may have anti-inflammatory properties, Nat. Med., 5, 69, 10.1038/9550 Willoughby, 2001, COX-1, COX-2 and COX-3 and the future treatment of chronic inflammatory disease, Lancet, 355, 646, 10.1016/S0140-6736(99)12031-2 Na, 2003, Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation, Biochem. Pharmacol., 66, 1381, 10.1016/S0006-2952(03)00488-X Simmons, 1999, Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid anti-inflammatory drugs, Proc. Natl. Acad. Sci. U. S. A., 96, 3275, 10.1073/pnas.96.6.3275